about
Modified Nucleoside Triphosphates for In-vitro Selection TechniquesExpected and unexpected features of protein-binding RNA aptamersTargeting Th17 Cells with Small Molecules and Small Interference RNARecent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingAdvance of molecular imaging technology and targeted imaging agent in imaging and therapyAptamers in diagnostics and treatment of viral infectionsUse of Aptamers as Diagnostics Tools and Antiviral Agents for Human VirusesFit for the Eye: Aptamers in Ocular DisordersPlatelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.Specific capture and temperature-mediated release of cells in an aptamer-based microfluidic device.Aptamer in bioanalytical applications.Pharmacokinetics and Toxicity in Rats and Monkeys of coDbait: A Therapeutic Double-stranded DNA Oligonucleotide Conjugated to CholesterolTargeting von Willebrand factor and platelet glycoprotein Ib receptor.Aptamer against mannose-capped lipoarabinomannan inhibits virulent Mycobacterium tuberculosis infection in mice and rhesus monkeys.Aptamers and the next generation of diagnostic reagents.Designing anti-influenza aptamers: novel quantitative structure activity relationship approach gives insights into aptamer-virus interactionIn vitro selection of structure-switching, self-reporting aptamers.The notorious R.N.A. in the spotlight - drug or target for the treatment of diseaseStrategies for the discovery of therapeutic aptamers.CD4 aptamer-RORγt shRNA chimera inhibits IL-17 synthesis by human CD4(+) T cells.Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineDNA aptamers selectively target Leishmania infantum H2A protein.Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cellsVimentin in cancer and its potential as a molecular target for cancer therapy.Evaluation of antithrombotic activity of thrombin DNA aptamers by a murine thrombosis model.Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic AgentsAptamer technology for tracking cells' status & function.Selective Targeting to Glioma with Nucleic Acid AptamersScreening and Identification of ssDNA Aptamer for Human GP73.SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.Dynamics and visualization of MCF7 adenocarcinoma cell death by aptamer-C1q-mediated membrane attack.Broadly reactive aptamers targeting bacteria belonging to different genera using a sequential toggle cell-SELEXStrand directionality affects cation binding and movement within tetramolecular G-quadruplexes.Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection.Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein.Safety evaluation of intravenously administered mono-thioated aptamer against E-selectin in mice.Oligonucleotide delivery in cancer therapy.Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases.Targeting transcription factor Stat5a/b as a therapeutic strategy for prostate cancer.Aptamer-conjugated nanomaterials and their applications.
P2860
Q26747256-80F6487C-78DC-4395-9F31-166AD0106A0CQ26750235-D5CA3A38-FF75-4DC0-9846-9C14AEB2D598Q26770523-383C4144-E4C4-4DCB-A235-67863F9FCF2CQ26778234-09B72118-0741-4643-BA62-77AA564910A0Q26851887-0DB7C4ED-FE06-40EF-A2C2-FE2A80F48594Q27014527-F0B6F5AD-AC0E-4F8C-8602-E057B7A2EA29Q28079654-C2370826-32D0-4B3D-892F-048B0AA05726Q28828283-B505A8C4-F47A-45EF-83BE-F5281909881BQ30250273-DD654083-8B4F-4EF1-9AA7-7379347C1DBFQ30440489-90935AD6-46DA-411C-8F5B-5E7BA2C56A1DQ30466572-F778C7BF-4915-448E-B162-CEAFD86D7D70Q30523973-C33766E0-0280-4CF1-8A24-403215181DF1Q33392975-D9A06D4C-E6E3-4173-8E0C-B1A1B8348E33Q33586979-E5A5B09C-8883-4433-A88D-D847D012CC52Q33615065-DF552F80-5C31-45E1-B133-BF7F40F629A7Q33638356-1CE8696E-B0C7-4FC1-BCD6-50E4CD9D6F54Q33641118-B99A9EE9-EB5C-4B91-B0FB-814F9F7D4F0DQ33739733-27895165-CF14-47D7-A2ED-14A9C86AC5D5Q33831862-6D0E6E3B-224E-43B5-B28D-3B4EC5BD2D2FQ34435503-CB46EF34-5404-4AE9-B687-D6266838332EQ34698624-0C632297-58E9-44F8-80C4-746700888CAFQ35036810-1D844C62-4910-43AB-BE58-7FA0EC6E226DQ35142045-7E3F55E5-8A22-410C-920B-2D948291A2B3Q35182104-F25D80EC-80CD-40ED-AA18-1FBFABC30428Q35239708-D7F54A4B-C0FB-49EA-B0AC-E2ED8C69FA87Q35309726-78EA629B-9FA6-418B-9AD1-7ECA7E1D8A8CQ35673895-BD46DF97-9FAA-486C-9CD0-E6B4D6F0AA3BQ35740074-B5880B1A-0C7B-4EC5-840C-ED31E8B83C55Q35846014-CFAA9A9A-C599-45EE-A59D-DD14714337D7Q35958678-FBCB18DB-6F87-48C0-920E-2F6DB66E467FQ36184701-25D59091-F47E-4FC0-93AA-342E906C749BQ36300521-3E3E06B8-578E-4AB3-95BE-A2CA74B916B1Q36435068-01D7C4E1-3BA6-4CCA-9866-010B1243764EQ36448777-5EB9208B-31C3-41C2-9B26-51B15F378631Q36939736-AD9A1CD8-AE29-460C-BEAC-E454585BF864Q37138307-7A72174C-8228-42AF-8524-B3F881C2F6A4Q37803214-D9EDB9F9-8CB2-408A-B9C2-F00ED583B6B7Q37815481-262B219D-B86C-4829-9252-669E4A8C2766Q37854477-723FE72E-368F-4612-925F-F0C4C36B9D76Q37948000-1CD7A003-79BA-4547-A836-30C590280B74
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Discovery and development of therapeutic aptamers.
@ast
Discovery and development of therapeutic aptamers.
@en
Discovery and development of therapeutic aptamers.
@nl
type
label
Discovery and development of therapeutic aptamers.
@ast
Discovery and development of therapeutic aptamers.
@en
Discovery and development of therapeutic aptamers.
@nl
prefLabel
Discovery and development of therapeutic aptamers.
@ast
Discovery and development of therapeutic aptamers.
@en
Discovery and development of therapeutic aptamers.
@nl
P2093
P1476
Discovery and development of therapeutic aptamers.
@en
P2093
K M Thompson
P R Bouchard
R M Hutabarat
P304
P356
10.1146/ANNUREV.PHARMTOX.010909.105547
P577
2010-01-01T00:00:00Z